Panagora Asset Management Inc Protagonist Therapeutics, Inc Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$23.34 - $36.08 $168,631 - $260,678
-7,225 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$17.63 - $37.1 $426,857 - $898,265
-24,212 Reduced 77.02%
7,225 $247,000
Q3 2021

Nov 10, 2021
SELL
$12.95 - $49.69 $1.37 Million - $5.26 Million
-105,761 Reduced 77.09%
31,437 $557,000
Q2 2021

Aug 11, 2021
SELL
$25.57 - $44.88 $2.36 Million - $4.14 Million
-92,315 Reduced 40.22%
137,198 $6.16 Million
Q1 2021

May 12, 2021
SELL
$19.02 - $31.15 $136,354 - $223,314
-7,169 Reduced 3.03%
229,513 $5.94 Million
Q4 2020

Feb 10, 2021
BUY
$18.49 - $25.13 $1.44 Million - $1.96 Million
77,828 Added 48.99%
236,682 $4.77 Million
Q3 2020

Nov 13, 2020
BUY
$15.19 - $22.4 $123,950 - $182,784
8,160 Added 5.41%
158,854 $3.11 Million
Q2 2020

Aug 12, 2020
BUY
$6.19 - $18.84 $651,157 - $1.98 Million
105,195 Added 231.2%
150,694 $2.66 Million
Q1 2020

May 14, 2020
BUY
$5.4 - $9.22 $245,694 - $419,500
45,499 New
45,499 $321,000
Q4 2018

Feb 14, 2019
SELL
$6.3 - $10.44 $19,574 - $32,437
-3,107 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$6.82 - $11.26 $18,182 - $30,019
-2,666 Reduced 46.18%
3,107 $32,000
Q1 2018

May 15, 2018
BUY
$8.46 - $23.08 $48,839 - $133,240
5,773 New
5,773 $50,000

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.92B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email